Indonesia Pushes for Pharmaceutical Sovereignty at ITS Surabaya Event
Taruna Ikrar championed Indonesia's pharmaceutical sovereignty at a conference held at ITS Surabaya. This initiative appears to be part of a broader effort to bolster the nation's drug manufacturing independence and improve public access to medicines.
Read up to 3 eligible full articles per Japan day (JST) for free
Create a free account to open up to 3 eligible full articles per Japan calendar day (JST). Headlines and summaries remain available across ASEAN 7.
Related articles
- Sinar Mas Group Becomes New Controller of KETR
PT Inti Mas Bangun Sejahtera (IMBS) acquired a 35% stake in PT Ketrosden Triasmitra Tbk (KETR), making the Sinar Mas Group its new controlling shareholder. This development is expected to influence KETR's infrastructure business, particularly in the submarine cable sector.
- KEEN Secures Rp 21.9 Trillion Power Projects from PLN
PT Kencana Energi Lestari Tbk (KEEN) has secured a major contract from state-owned electricity company PT PLN (Persero) for the construction and operation of two hydropower plants (PLTA) valued at US$1.20 billion (approximately Rp 21.9 trillion). This deal is expected to significantly enhance KEEN's operational continuity and revenue.
- Indonesian Gold Prices Expected to Fluctuate on November 13
PT Antam Tbk (ANTM) gold bar prices in Indonesia are projected to fluctuate on November 13. Experts anticipate a temporary decline followed by a potential rebound and rise within the week.
- Petrosea (PTRO) Moderates Capital Expenditure in 2026 Amidst Operational Optimization
PT Petrosea Tbk (PTRO) is moderating its capital expenditure (capex) for 2026, following a significant investment phase in 2025. The company aims to optimize its expanded asset base and maintain financial health.